Labcorp (LH) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
Research notes will appear with the next update.
What does Labcorp (LH) do?
Labcorp Holdings Inc (LH) is a U.S.-listed company in Healthcare (Diagnostics & Research). What it does: Provides diagnostic, clinical laboratory, and esoteric testing services to healthcare providers and patients. Operates an extensive network of clinical testing laboratories processing millions of patient specimens each week. It is worth $29.95B on the market and sold $14.61B over the last year.
- Market cap
- $29.95B
- P/E ratio
- 30.3×
- Annual sales
- $14.61B
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Brief updated
- Nov 09, 2026
Brands and businesses behind LH
- Labcorp OnDemand: Sells direct-to-consumer health and wellness blood tests online without requiring an upfront doctor visit.
- Integrated Genetics: Provides prenatal and hereditary genetic screening tests billed directly to patients and health insurers.
- Monogram Biosciences: Offers precision virology and oncology lab assays to guide personalized treatment decisions for clinics.
- Dianon Pathology: Delivers anatomic pathology testing for cancer diagnostics, billing physicians and commercial health plans.
- Litholink: Provides specialized diagnostic testing to help physicians identify and manage chronic kidney stone recurrence.
LH’s flags, in plain English
Each flag is a number from Labcorp’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 09, 2026.
Growth Cooling
Sales growth slowed to -0% a year over 5 years. Sales are growing more slowly than before, which makes the current share price harder to justify.
Questions about LH
How big is Labcorp?
Labcorp’s market cap is $29.95B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $14.61B: what customers paid the company over the last year, before any costs.
What is LH’s P/E ratio?
LH’s P/E ratio is 30.3×. Investors pay about 30.3 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with LH?
Periodic rate cuts mandated by Medicare under federal lab fee schedules continuously lower reimbursement on common blood tests. That is one risk on Labcorp’s card. Its first risk flag is Growth Cooling, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Labcorp’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. LH’s filings on SEC.gov. The Margin Monkey is research, not advice.
